BE2011C024I2 - - Google Patents

Info

Publication number: BE2011C024I2
Authority: BE; Belgium

Application number

BE2011C024C

Original Assignee

Palau Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

2011-07-27

Publication date

2019-03-05

2011-07-27 Application filed by Palau Pharma Sa filed Critical Palau Pharma Sa

2019-03-05 Publication of BE2011C024I2 publication Critical patent/BE2011C024I2/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BE2011C024C 1998-10-16 2011-07-27 BE2011C024I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES9802222		1998-10-16
PCT/ES1999/000327 WO2000023426A1 (fr)	1998-10-16	1999-10-15	Nouveaux imidazoles a activite anti-inflammatoire

Publications (1)

Publication Number	Publication Date
BE2011C024I2 true BE2011C024I2 (fr)	2019-03-05

Family

ID=8305557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2011C024C BE2011C024I2 (fr)	1998-10-16	2011-07-27

Country Status (20)

Country	Link
US (1)	US6838476B1 (fr)
EP (1)	EP1122243B1 (fr)
JP (1)	JP4480894B2 (fr)
KR (2)	KR100715918B1 (fr)
AR (1)	AR024222A1 (fr)
AT (1)	ATE275549T1 (fr)
AU (1)	AU6204899A (fr)
BE (1)	BE2011C024I2 (fr)
BR (2)	BR9914571A (fr)
CA (1)	CA2346847C (fr)
CY (1)	CY2011009I1 (fr)
DE (2)	DE69920028T2 (fr)
DK (1)	DK1122243T3 (fr)
ES (1)	ES2228109T3 (fr)
FR (1)	FR11C0028I2 (fr)
HK (1)	HK1039331B (fr)
LU (1)	LU91849I2 (fr)
NO (2)	NO319074B1 (fr)
PT (1)	PT1122243E (fr)
WO (1)	WO2000023426A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2362815A1 (fr)	1999-12-08	2001-06-14	Pharmacia Corporation	Compositions d'inhibiteur de cyclooxygenase-2 produisant rapidement un effet therapeutique
ES2159489B1 (es)	2000-03-23	2002-04-16	Uriach & Cia Sa J	Nuevos derivados de imidazol con actividad antiinflamatoria.
ES2166710B1 (es) *	2000-04-25	2004-10-16	J. URIACH & CIA, S.A.	Nuevos compuestos heterociclicos con actividad antiinflamatoria.
ES2184633B1 (es)	2001-08-07	2004-08-01	J. URIACH & CIA, S.A.	Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
AU2003216579A1 (en) *	2002-04-12	2003-10-27	Pfizer Inc.	Imidazole compounds as anti-inflammatory and analgesic agents
KR100804827B1 (ko) *	2002-05-17	2008-02-20	씨제이제일제당 (주)	티아졸리딘-4-온 유도체, 그 제조방법 및 약제학적 조성물
WO2004009558A2 (fr) *	2002-07-24	2004-01-29	Ptc Therapeutics, Inc.	Composes d'acide benzoique a substitution ureido et leur utilisation pour la suppression de non-sens et le traitement de maladie
ES2215474B1 (es) *	2002-12-24	2005-12-16	J. URIACH & CIA S.A.	Nuevos derivados de fosforamida.
FR2881049B1 (fr) *	2005-01-24	2008-12-26	Vetoquinol Sa Sa	Medicament destine a etre administre par voie orale comprenant un inhibiteur de la cyclo-oxygenase-2, et son procede de preparation
WO2009005675A1 (fr)	2007-06-28	2009-01-08	Abbott Laboratories	Nouvelles triazolopyridazines
GB0806745D0 (en) *	2008-04-14	2008-05-14	Syngenta Participations Ag	Novel imidazole derivatives
WO2010068794A2 (fr)	2008-12-10	2010-06-17	The General Hospital Corporation	Inhibiteurs de hif et leurs applications
US20110045101A1 (en) *	2009-05-06	2011-02-24	E.I. Du Pont De Nemours And Company	Fungicidal substituted azoles
CN102464652B (zh) *	2010-11-02	2013-08-28	北京欧博方医药科技有限公司	咪唑衍生物、制备方法及用途
US20240165148A1 (en)	2021-03-15	2024-05-23	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3901908A (en) *	1970-12-28	1975-08-26	Ciba Geigy Corp	2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
IT1168008B (it) *	1981-07-31	1987-05-20	Zambon Spa	Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono
US4576958A (en) *	1984-01-23	1986-03-18	E. I. Du Pont De Nemours And Company	Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en) *	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
EE03685B1 (et) *	1996-04-12	2002-04-15	G.D. Searle & Co.	Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid

1999
- 1999-10-13 AR ARP990105192A patent/AR024222A1/es active IP Right Grant
- 1999-10-15 DK DK99949025T patent/DK1122243T3/da active
- 1999-10-15 EP EP99949025A patent/EP1122243B1/fr not_active Expired - Lifetime
- 1999-10-15 CA CA002346847A patent/CA2346847C/fr not_active Expired - Lifetime
- 1999-10-15 AT AT99949025T patent/ATE275549T1/de active
- 1999-10-15 JP JP2000577154A patent/JP4480894B2/ja not_active Expired - Fee Related
- 1999-10-15 BR BR9914571-5A patent/BR9914571A/pt not_active IP Right Cessation
- 1999-10-15 BR BRPI9914571-5 patent/BRPI9914571B8/pt unknown
- 1999-10-15 WO PCT/ES1999/000327 patent/WO2000023426A1/fr not_active Application Discontinuation
- 1999-10-15 PT PT99949025T patent/PT1122243E/pt unknown
- 1999-10-15 DE DE69920028T patent/DE69920028T2/de not_active Expired - Lifetime
- 1999-10-15 ES ES99949025T patent/ES2228109T3/es not_active Expired - Lifetime
- 1999-10-15 KR KR1020017004779A patent/KR100715918B1/ko not_active Expired - Lifetime
- 1999-10-15 US US09/807,458 patent/US6838476B1/en not_active Expired - Lifetime
- 1999-10-15 AU AU62048/99A patent/AU6204899A/en not_active Abandoned
- 1999-10-15 DE DE201112100028 patent/DE122011100028I1/de active Pending
- 1999-10-15 KR KR1020067024215A patent/KR100808433B1/ko not_active Expired - Lifetime
2001
- 2001-04-09 NO NO20011790A patent/NO319074B1/no not_active IP Right Cessation
2002
- 2002-02-04 HK HK02100832.0A patent/HK1039331B/zh not_active IP Right Cessation
2011
- 2011-07-27 NO NO2011012C patent/NO2011012I2/no unknown
- 2011-07-27 LU LU91849C patent/LU91849I2/fr unknown
- 2011-07-27 BE BE2011C024C patent/BE2011C024I2/fr unknown
- 2011-07-28 FR FR11C0028C patent/FR11C0028I2/fr active Active
- 2011-08-10 CY CY2011009C patent/CY2011009I1/el unknown

Also Published As

Publication number	Publication date
FR11C0028I1 (fr)	2011-09-23
DE69920028D1 (de)	2004-10-14
NO2011012I2 (no)	2013-05-06
ES2228109T3 (es)	2005-04-01
CA2346847C (fr)	2009-12-22
CY2011009I2 (el)	2014-04-09
HK1039331B (zh)	2005-01-07
KR20010080186A (ko)	2001-08-22
KR20060129102A (ko)	2006-12-14
DK1122243T3 (da)	2005-01-10
LU91849I2 (fr)	2011-09-27
NO20011790D0 (no)	2001-04-09
WO2000023426A1 (fr)	2000-04-27
BR9914571A (pt)	2001-11-06
NO319074B1 (no)	2005-06-13
BRPI9914571A (pt)	2001-11-06
FR11C0028I2 (fr)	2012-06-22
AU6204899A (en)	2000-05-08
JP4480894B2 (ja)	2010-06-16
CA2346847A1 (fr)	2000-04-27
NO20011790L (no)	2001-06-14
DE69920028T2 (de)	2005-09-22
KR100715918B1 (ko)	2007-05-08
JP2002527508A (ja)	2002-08-27
AR024222A1 (es)	2002-09-25
EP1122243A1 (fr)	2001-08-08
PT1122243E (pt)	2004-12-31
ATE275549T1 (de)	2004-09-15
HK1039331A1 (en)	2002-04-19
EP1122243B1 (fr)	2004-09-08
US6838476B1 (en)	2005-01-04
CY2011009I1 (el)	2014-04-09
KR100808433B1 (ko)	2008-03-03
NO2011012I1 (no)	2011-08-08
DE122011100028I1 (de)	2011-12-08
BRPI9914571B8 (pt)	2021-07-06
BRPI9914571B1 (pt)	2011-10-18

Publication	Publication Date	Title
BE2012C041I2 (fr)	2019-03-05
BRPI9917862A2 (fr)	2010-12-07
BE2011C024I2 (fr)	2019-03-05
BRPI9816295A2 (fr)	2011-11-22
CN3078962S (fr)	1998-06-03
CN3081498S (fr)	1998-07-15
BY4669C1 (fr)	2002-09-30
CN3071793S (fr)	1998-01-07
CN3072688S (fr)	1998-01-21
CN3072760S (fr)	1998-01-21
CN3072873S (fr)	1998-01-21
CN3073425S (fr)	1998-01-28
CN3073771S (fr)	1998-02-04
CN3073964S (fr)	1998-02-11
CN3074052S (fr)	1998-02-11
CN3074053S (fr)	1998-02-11
CN3074054S (fr)	1998-02-11
CN3074474S (fr)	1998-02-18
CN3074547S (fr)	1998-02-18
CN3074693S (fr)	1998-02-18
CN3075068S (fr)	1998-02-25
CN3075591S (fr)	1998-03-18
CN3075658S (fr)	1998-03-18
CN3076421S (fr)	1998-04-01
CN3076442S (fr)	1998-04-08